| UHC Medicare Advantage | Positron Emission Tomography (PET) Scan for Myocardial Imaging - Medicare Advantage Medical Policy | 2025-05-01 |
| UHC UMR Medical and Drug | Crysvita® (Burosumab-Twza) – Commercial Medical Benefit Drug Policy | 2025-05-01 |
| UHC UMR Medical and Drug | Parsabiv® (Etelcalcetide) – Commercial Medical Benefit Drug Policy | 2025-05-01 |
| UHC UMR Medical and Drug | Tzield® (Teplizumab-Mzwv) – Commercial Medical Benefit Drug Policy | 2025-05-01 |
| UHC Surest Medical and Drug | Crysvita® (Burosumab-Twza) – Commercial Medical Benefit Drug Policy | 2025-05-01 |
| UHC Surest Medical and Drug | Parsabiv® (Etelcalcetide) – Commercial Medical Benefit Drug Policy | 2025-05-01 |
| UHC Surest Medical and Drug | Tzield® (Teplizumab-Mzwv) – Commercial Medical Benefit Drug Policy | 2025-05-01 |
| BCBS North Carolina | Beta Amyloid Imaging with Positron Emission Tomography for Alzheimer's Disease | Providers | 2025-05-01 |
| BCBS North Carolina | Lumbar Spine Procedures | Providers | 2025-05-01 |
| BCBS North Carolina | Percutaneous Intradiscal and Intraosseous Radiofrequency Procedures of the Spine | Providers | 2025-05-01 |